论文部分内容阅读
目的观察氢化可的松治疗肺炎支原体引起的小儿大叶性肺炎短期的临床疗效。方法选取2014年2月-2015年2月医院收治的肺炎支原体引起的小儿大叶性肺炎患儿78例,按随机数字表法分为观察组和对照组各39例;对照组给予常规方法治疗,观察组在常规方法治疗的基础上,短期应用氢化可的松治疗;对2组临床治疗效果进行对比评价。结果观察组总有效率为94.87%明显高于对照组的76.92%,差异有统计学意义(P<0.05)。观察组患儿退热时间为(4.6±0.3)d、住院时间为(8.5±0.4d)明显短于对照组的(10.8±0.7)d、(12.7±1.2)d,差异有统计学意义(P<0.05)。2组不良反应发生率比较差异无统计学意义(P>0.05)。结论肺炎支原体引起的小儿大叶性肺炎患儿,短期加用氢化可的松治疗效果显著;能够缩短退热时间及住院时间,缓解发热、咳嗽症状,并控制不良反应的发生;因此,值得在临床中采纳应用。
Objective To observe the clinical efficacy of hydrocortisone in the treatment of Mycoplasma pneumoniae short-term pediatric pneumonia caused by pneumonia. Methods 78 cases of children with lobar pneumonia caused by Mycoplasma pneumoniae were enrolled in the hospital from February 2014 to February 2015. The children were divided into observation group and control group according to random number table method, 39 cases each. The control group was given routine treatment . The observation group was treated with hydrocortisone on a short-term basis on the basis of routine treatment. The clinical effects of the two groups were compared and evaluated. Results The total effective rate was 94.87% in the observation group was significantly higher than 76.92% in the control group, the difference was statistically significant (P <0.05). The duration of antipyretic fever in observation group was (4.6 ± 0.3) days, and the length of stay in hospital was (8.5 ± 0.4 days) was significantly shorter than that in control group (10.8 ± 0.7 days, 12.7 ± 1.2 days) P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion Mycoplasma pneumoniae in children with lobar pneumonia in children with short-term treatment with hydrocortisone significant effect; can reduce the fever and hospital stay, relieve fever, cough, and control the incidence of adverse reactions; therefore, it is worth Clinical application.